A Monte Carlo-based analytic model of neutron dose equivalent for a mevion gantry-mounted passively scattered proton system for craniospinal irradiation
- PMID: 32473612
- DOI: 10.1002/mp.14299
A Monte Carlo-based analytic model of neutron dose equivalent for a mevion gantry-mounted passively scattered proton system for craniospinal irradiation
Abstract
Purpose: To calculate in- and out-of-field neutron spectra and dose equivalent, using Monte Carlo (MC) simulation, for a Mevion gantry-mounted passively scattered proton system in craniospinal irradiation. An analytical model based on the MC calculations that estimates in- and out-of-field neutron dose equivalent from proton Craniospinal irradiation (CSI) was also developed.
Methods: The MCNPX MC code was used to simulate a Mevion S250 proton therapy system. The simulated proton depth doses and profiles for pristine and spread-out Bragg peaks were benchmarked against the measured data. Previous measurements using extended-range Bonner spheres were used to verify the calculated neutron spectra and dose equivalent. Using the benchmarked results as a reference condition, a correction-based analytical model was reconstructed by fitting the data to derive model parameters at 95% confidence interval. Sensitivity analysis of brass aperture opening, thickness of the Lucite (PMMA) range compensator, and modulation width was performed to obtain correction parameters for nonreference conditions.
Results: For the neutron dose equivalent per therapeutic proton dose, the MCNPX calculated dose equivalent matched the measured values to within 8%. The benchmarked neutron dose equivalent at the isocenter was 41.2 and 20.8 mSv/Gy, for cranial and spinal fields, respectively. For in- and out-of-field neutron dose calculations, the correction-based analytical model showed up to 17% discrepancy compared to the MC calculations. The correction factors may provide a conservative estimation of neutron dose, especially for depth ≤ 5 cm and regions underneath the brass aperture.
Conclusion: The proposed analytical model can be used to estimate the contribution of the neutron dose to the overall CSI treatment dose. Moreover, the model can be employed to estimate the neutron dose to the implantable cardiac electronic devices.
Keywords: MCNP; analytic model; craniospinal irradiation; neutron dose equivalent; passively scattered proton.
© 2020 American Association of Physicists in Medicine.
Similar articles
-
Determining Out-of-Field Doses and Second Cancer Risk From Proton Therapy in Young Patients-An Overview.Front Oncol. 2022 May 31;12:892078. doi: 10.3389/fonc.2022.892078. eCollection 2022. Front Oncol. 2022. PMID: 35712488 Free PMC article. Review.
-
A Monte Carlo based analytic model of the in-room neutron ambient dose equivalent for a Mevion gantry-mounted passively scattered proton system.J Radiol Prot. 2020 Sep 23;40(4):980-996. doi: 10.1088/1361-6498/abaff4. Online ahead of print. J Radiol Prot. 2020. PMID: 32964859
-
Measured Neutron Spectra and Dose Equivalents From a Mevion Single-Room, Passively Scattered Proton System Used for Craniospinal Irradiation.Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):249-257. doi: 10.1016/j.ijrobp.2015.12.356. Epub 2015 Dec 19. Int J Radiat Oncol Biol Phys. 2016. PMID: 27084645
-
Sensitivity analysis of Monte Carlo model of a gantry-mounted passively scattered proton system.J Appl Clin Med Phys. 2020 Feb;21(2):26-37. doi: 10.1002/acm2.12803. Epub 2020 Jan 3. J Appl Clin Med Phys. 2020. PMID: 31898873 Free PMC article.
-
Validation of a Monte Carlo Framework for Out-of-Field Dose Calculations in Proton Therapy.Front Oncol. 2022 Jun 8;12:882489. doi: 10.3389/fonc.2022.882489. eCollection 2022. Front Oncol. 2022. PMID: 35756661 Free PMC article.
Cited by
-
Evaluation of the dosimetric effect of scattered protons in clinical practice in passive scattering proton therapy.J Appl Clin Med Phys. 2021 Jun;22(6):104-118. doi: 10.1002/acm2.13284. Epub 2021 May 25. J Appl Clin Med Phys. 2021. PMID: 34036701 Free PMC article.
-
Risk of cardiac implantable device malfunction in cancer patients receiving proton therapy: an overview.Front Oncol. 2023 Jul 4;13:1181450. doi: 10.3389/fonc.2023.1181450. eCollection 2023. Front Oncol. 2023. PMID: 37469405 Free PMC article. Review.
-
Determining Out-of-Field Doses and Second Cancer Risk From Proton Therapy in Young Patients-An Overview.Front Oncol. 2022 May 31;12:892078. doi: 10.3389/fonc.2022.892078. eCollection 2022. Front Oncol. 2022. PMID: 35712488 Free PMC article. Review.
References
REFERENCES
-
- Newhauser WD, Zhang R. The physics of proton therapy. Phys Med Biol. 2015;60:R155-R209.
-
- Zhao T, Sun B, Grantham K, et al. Commissioning and initial experience with the first clinical gantry-mounted proton therapy system. J Appl Clin Med Phys. 2016;17:24-40.
-
- Chen KL, Bloch CD, Hill PM, Klein EE. Evaluation of neutron dose equivalent from the Mevion S250 proton accelerator: measurements and calculations. Phys Med Biol. 2013;58:8709-8723.
-
- Kry SF, Salehpour M, Followill DS, et al. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2005;62:1204-1216.
-
- Taddei PJ, Mahajan A, Mirkovic D, et al. Predicted risks of second malignant neoplasm incidence and mortality due to secondary neutrons in a girl and boy receiving proton craniospinal irradiation. Phys Med Biol. 2010;55:7067-7080.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources